Retatrutide is still in phase 3 trials, which means it isnt available outside of research settings yet
**Conclusion:** Based on the current lack of safety data, Tirzepatide (Zepbound) is **generally not recommended for weight loss while breastfeeding.** If you are postpartum and *not* breastfeeding, using Zepbound is a possibility *only if* you meet the standard FDA eligibility criteria and have adequately recovered from childbirth
Thanks for the brilliant breakdown!
You might say, Ive been working with my doctor, and were trying different approachesand Im really glad about that. Often, though, the simplest response is to ignore them. Manage potential GLP-1 side effects Many patients hear alarming stories online or in the news about GLP-1 receptor agonist side effects, acknowledges obesity medicine physician Richele Corrado, DO
Lau, J., Bloch, P., Schffer, L., Pettersson, I., Spetzler, J., Kofoed, J., & Knudsen, L.B
Pricing & membership options Most national brands advertise low monthly rates but add hidden fees for shipping, labs, membership, or priority support. Many charge $149$490/month before add-ons
%20(1).png)
